IGC Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2005
Net Income	-11.51	-15.02	-8.81	-7.32	-4.1	-1.79	-1.87	-2.81	-4.61	-3.02	Upgrade
Depreciation & Amortization	0.66	0.65	0.48	0.14	0.06	0.02	0.4	0.73	0.78	0.71	Upgrade
Share-Based Compensation	2.84	2.2	0.66	0.77	0.61	0.58	0.25	0.21	0.83	0.18	Upgrade
Other Operating Activities	0.96	4.71	-3.13	-2.28	0.1	-0.74	-0.17	1.71	0.42	0.39	Upgrade
Operating Cash Flow	-7.05	-7.46	-10.8	-8.68	-3.33	-1.93	-1.39	-0.16	-2.58	-1.74	Upgrade
Capital Expenditures	0.23	-0.21	-1.47	-4.39	-0.02	-0.14	-0.15	-0.12	-0.08	0	Upgrade
Acquisitions	0	0	0	0	0	-0.46	0	0.02	0.17	0	Upgrade
Change in Investments	-0.15	0	4.98	-5.08	-0.2	0	-0.1	-0.08	0	0	Upgrade
Other Investing Activities	-0.31	-0.54	-0.12	-0.08	-0.05	-0.07	-	-0	-0.61	-	Upgrade
Investing Cash Flow	-0.24	-0.74	3.39	-9.55	-0.26	-0.66	-0.24	-0.18	-0.52	0	Upgrade
Share Issuance / Repurchase	0.1	4.15	14.16	-0.06	29.48	3.49	0.64	1.74	2.96	1.76	Upgrade
Debt Issued / Paid	-0	-0	0.53	0	-1.88	0.04	0.2	-0.73	-0.06	-0.02	Upgrade
Other Financing Activities	-	-	-	-	-	0.19	-0.14	-	-	-	Upgrade
Financing Cash Flow	0.1	4.14	14.69	-0.06	27.6	3.72	0.71	1.01	2.9	1.74	Upgrade
Exchange Rate Effect	-0.08	-0.03	0.02	-0.07	-0.06	-0.01	-0.03	-0	-0	-0.04	Upgrade
Net Cash Flow	-7.26	-4.09	7.29	-18.35	23.95	1.12	-0.95	0.67	-0.2	-0.04	Upgrade
Free Cash Flow	-6.82	-7.67	-12.27	-13.07	-3.35	-2.07	-1.54	-0.28	-2.66	-1.74	Upgrade
Free Cash Flow Margin	-748.52%	-1931.74%	-1366.37%	-320.87%	-65.38%	-94.25%	-264.79%	-4.40%	-34.64%	-76.50%	Upgrade
Free Cash Flow Per Share	-0.13	-0.15	-0.29	-0.33	-0.10	-0.07	-0.06	-0.02	-0.18	-0.21	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).